24 related articles for article (PubMed ID: 33089949)
21. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
Grobner T
Nephrol Dial Transplant; 2006 Apr; 21(4):1104-8. PubMed ID: 16431890
[No Abstract] [Full Text] [Related]
22. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
Heywang-Köbrunner SH; Haustein J; Pohl C; Beck R; Lommatzsch B; Untch M; Nathrath WB
Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
[TBL] [Abstract][Full Text] [Related]
24. Effect of contrast dose on diagnostic performance in DCE-MR breast imaging.
Le TT; McDonald ES; Isaac G; Rosen MA; Dougherty L
J Appl Clin Med Phys; 2020 Nov; 21(11):188-194. PubMed ID: 33089949
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
